ID: ALA5183282

Max Phase: Preclinical

Molecular Formula: C23H19FN6O2

Molecular Weight: 430.44

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]c(=O)n(C2CC2)c2nc(Cc3nc4ccc(F)cc4[nH]3)n(Cc3ccccc3)c12

Standard InChI:  InChI=1S/C23H19FN6O2/c24-14-6-9-16-17(10-14)26-18(25-16)11-19-27-21-20(29(19)12-13-4-2-1-3-5-13)22(31)28-23(32)30(21)15-7-8-15/h1-6,9-10,15H,7-8,11-12H2,(H,25,26)(H,28,31,32)

Standard InChI Key:  HLFAVWDNJHBPGF-UHFFFAOYSA-N

Associated Targets(Human)

Tryptophan 5-hydroxylase 1 286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tryptophan 5-hydroxylase 2 43 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 430.44Molecular Weight (Monoisotopic): 430.1554AlogP: 2.88#Rotatable Bonds: 5
Polar Surface Area: 101.36Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.24CX Basic pKa: 5.61CX LogP: 3.18CX LogD: 3.17
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.70

References

1. Specker E, Matthes S, Wesolowski R, Schütz A, Grohmann M, Alenina N, Pleimes D, Mallow K, Neuenschwander M, Gogolin A, Weise M, Pfeifer J, Ziebart N, Heinemann U, von Kries JP, Nazaré M, Bader M..  (2022)  Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.,  65  (16.0): [PMID:35921615] [10.1021/acs.jmedchem.2c00598]

Source